Annual ROE
-34.10%
-36.26%-1678.70%
December 31, 2023
Summary
- As of February 21, 2025, BRNS annual return on equity is -34.10%, with the most recent change of -36.26% (-1678.70%) on December 31, 2023.
- During the last 3 years, BRNS annual ROE has fallen by -81.57% (-171.83%).
- BRNS annual ROE is now -171.83% below its all-time high of 47.47%, reached on December 1, 2020.
Performance
BRNS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-33.20%
+1.13%+3.29%
September 30, 2024
Summary
- As of February 21, 2025, BRNS quarterly return on equity is -33.20%, with the most recent change of +1.13% (+3.29%) on September 30, 2024.
- Over the past year, BRNS quarterly ROE has stayed the same.
- BRNS quarterly ROE is now -151.48% below its all-time high of 64.49%, reached on March 1, 2021.
Performance
BRNS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BRNS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1678.7% | 0.0% |
| 3 y3 years | -171.8% | -1651.4% |
| 5 y5 years | - | +57.3% |
BRNS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1678.7% | +27.7% | -824.9% | +14.5% |
| 5 y | 5-year | -171.8% | +27.7% | -151.5% | +57.3% |
| alltime | all time | -171.8% | +27.7% | -151.5% | +57.3% |
Barinthus Biotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -33.20%(-3.3%) |
| Jun 2024 | - | -34.33%(-2.3%) |
| Mar 2024 | - | -35.13%(+3.1%) |
| Dec 2023 | -34.10%(-1678.7%) | -34.06%(0.0%) |
| Sep 2023 | - | -34.06%(+48.0%) |
| Jun 2023 | - | -23.02%(+266.6%) |
| Mar 2023 | - | -6.28%(-393.5%) |
| Dec 2022 | 2.16% | 2.14%(-53.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 4.58%(-932.7%) |
| Jun 2022 | - | -0.55%(-96.8%) |
| Mar 2022 | - | -17.46%(-55.0%) |
| Dec 2021 | -47.17%(-199.4%) | - |
| Dec 2021 | - | -38.82%(-15.4%) |
| Sep 2021 | - | -45.90%(-40.9%) |
| Jun 2021 | - | -77.72%(-220.5%) |
| Mar 2021 | - | 64.49%(+35.9%) |
| Dec 2020 | 47.47% | 47.47% |
FAQ
- What is Barinthus Biotherapeutics annual return on equity?
- What is the all time high annual ROE for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual ROE year-on-year change?
- What is Barinthus Biotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly ROE year-on-year change?
What is Barinthus Biotherapeutics annual return on equity?
The current annual ROE of BRNS is -34.10%
What is the all time high annual ROE for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual return on equity is 47.47%
What is Barinthus Biotherapeutics annual ROE year-on-year change?
Over the past year, BRNS annual return on equity has changed by -36.26% (-1678.70%)
What is Barinthus Biotherapeutics quarterly return on equity?
The current quarterly ROE of BRNS is -33.20%
What is the all time high quarterly ROE for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly return on equity is 64.49%
What is Barinthus Biotherapeutics quarterly ROE year-on-year change?
Over the past year, BRNS quarterly return on equity has changed by 0.00% (0.00%)